WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Leveraging ANALYTICS to Drive Population Health
June 4, 2018
I'm For Real
Enter your details once to access all our information and resources
The Permanente Medical Groups are physician-led, independent medical groups that provide exclusive care to the patients and members of Kaiser Permanente.
whitePaper | May 20, 2022
Starting your own telemedicine practice or expanding your virtual care services? With the telehealth transformation underway,
whitePaper | February 15, 2022
Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.
whitePaper | February 19, 2020
Technology investment is just part of revenue cycle management, and engaging patients in the financial side of their treatment will be a key theme at HIMSS20. It contains patient engagement in their medical bills, pricing transparency when choosing treatments and medications ,organizational integration of revenue cycle management, automation of prior authorization
whitePaper | June 28, 2022
Healthcare decisions are no longer confined to the four walls of a hospital. To keep pace with the emerging needs of patients and clinicians as well as the telehealth revolution.
whitePaper | December 10, 2022
Healthcare’s workforce is in crisis. Waves of employee departures amid a once-in-a-century public health crisis have left hospitals all over the nation scrambling to fill critical roles across the enterprise.
whitePaper | June 24, 2023
A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.
Conference
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE